TNF Inhibitor Therapy for Psoriasis May Lower CVD Risk
When used to treat psoriasis, agents that inhibit tumor necrosis factor (TNF) may have the added benefit of reducing the excess cardiovascular risk associated with this disease, according to a meta-analysis published online in Clinical Reviews in Allergy & Immunology, and reported on www.medscape.com. The analysis of five studies and nearly 50,000 patients with psoriasis found that [...]